Thyroid Cancer Trial, Recruiting (NCT07041307)

Thyroid Cancer Trial, Recruiting NCT07041307 Sponsor: Rigshospitalet, Denmark Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07041307 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are willing and able to give your agreement to take part in the study, both in writing and verbally
You have a thyroid nodule that is overactive, underactive, or functioning normally
You have been referred for thyroid surgery because a nodule is suspected to possibly be cancerous (including certain biopsy result categories known as Bethesda III, IV, V, or VI — confirm with trial site if unsure which category applies to you)
Healthy volunteers may also be eligible if they are generally in good health with no long-term illnesses

Who may not be able to join:

You are currently pregnant
You are unable to take part in the examination due to physical or mental health limitations
You do not wish to be told about any new or important health findings that might be discovered during the study
Healthy volunteers may not be eligible if they have or have ever had any thyroid condition, including thyroid nodules
Healthy volunteers may not be eligible if they are currently taking any medication that affects how the thyroid works

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Bachmann Nielsen, Professor PhD dr.med., Rigshospitalet, Denmark

Phone: +4529273193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07041307

Sponsor: Rigshospitalet, Denmark

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: +4529273193

More information: https://clinicaltrials.gov/study/NCT07041307

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are willing and able to give your agreement to take part in the study, both in writing and verbally
You have a thyroid nodule that is overactive, underactive, or functioning normally
You have been referred for thyroid surgery because a nodule is suspected to possibly be cancerous (including certain biopsy result categories known as Bethesda III, IV, V, or VI — confirm with trial site if unsure which category applies to you)
Healthy volunteers may also be eligible if they are generally in good health with no long-term illnesses

Who may not be able to join:

You are currently pregnant
You are unable to take part in the examination due to physical or mental health limitations
You do not wish to be told about any new or important health findings that might be discovered during the study
Healthy volunteers may not be eligible if they have or have ever had any thyroid condition, including thyroid nodules
Healthy volunteers may not be eligible if they are currently taking any medication that affects how the thyroid works

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Rigshospitalet, Denmark

Registry

ClinicalTrials.gov

Start date

15 August 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Visualization of the Microvasculature in the Thyroid Gland and Thyroid Nodules

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov